SARS-CoV-2 – whole pathogen molecular controls are now available in Qnostics. Samples are representative of clinical human specimens and are traceable to an internal reference preparation in line with the requirements of ISO 17511:2003. The Panels are suitable for use with the majority of commercial and in-house molecular methods. For information, enquiries and technical bulletins,…
Qnostics Launches RSV and RV Molecular ‘Q’ Controls Glasgow, United Kingdom, 12th August 2014 – Qnostics Ltd. today announced the addition of another 2 target members to its own brand products. The Qnostics ‘Q’ Control range now includes Respiratory Syncytial virus (RSV) and Rhinovirus (RV), which brings the number of targets in this range to…
Glasgow, United Kingdom, 3rd July, 2014 – Qnostics Ltd. announced today that it has received CE Marked status for its new CMV molecular controls. These products are a welcome addition to the existing range of respiratory and transplant molecular controls. “The launch of the CMV CE Marked molecular controls is a major achievement for Qnostics.…
Glasgow, United Kingdom, 7th January, 2014 – Qnostics Ltd. serving molecular laboratories, today announced it has launched several new molecular controls for use within the testing procedures for a variety of respiratory and transplant assays. “The launch of our new molecular controls allows the company to further strengthen its Transplant range of molecular controls as…